IFNG and COVID-19: Overall, these results demonstrate the ability of a selected set of systemic mediators (IL-6, IFN-γ, IL-1Ra, IL-13, PDGF and IL-7) as putative laboratory markers that are applicable as complementary records in the clinical management of severe COVID-19 patients.